WATS3D® Significantly Boosts Barrett's Esophagus and Dysplasia Detection Rates in Landmark Clinical Study
Pivotal Multi-Center Study Highlights AI Platform's Powerful Diagnostic Impact and Ability to Enhance Patient Outcomes SUFFERN, N.Y., May 17, 2024 /PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and …